当前位置:首页 - 行情中心 - 迈普医学(301033) - 财务分析 - 现金流量表

迈普医学

(301033)

  

流通市值:31.03亿  总市值:36.92亿
流通股本:5635.37万   总股本:6704.96万

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金93,575,718.62401,608,194.11279,703,271.51183,049,028.02
  收到的税费返还-1,066,476.67342,635.58338,924.9
  收到其他与经营活动有关的现金1,010,502.3412,056,406.35,835,349.972,442,205.28
  经营活动现金流入小计94,586,220.96414,731,077.08285,881,257.06185,830,158.2
  购买商品、接受劳务支付的现金21,510,286.9457,071,846.7835,573,601.3219,733,698.59
  支付给职工以及为职工支付的现金37,993,484.198,752,712.6768,917,119.3347,411,634.52
  支付的各项税费13,926,775.0849,686,739.334,060,786.8124,736,660.99
  支付其他与经营活动有关的现金17,953,449.8469,353,099.7663,571,561.0437,427,210.8
  经营活动现金流出小计91,383,995.96274,864,398.51202,123,068.5129,309,204.9
  经营活动产生的现金流量净额3,202,225139,866,678.5783,758,188.5656,520,953.3
二、投资活动产生的现金流量:
  收回投资收到的现金123,034,078.62560,349,186.13475,217,471.23344,892,252.41
  取得投资收益收到的现金62,790--14,650-24,850
  处置固定资产、无形资产和其他长期资产收回的现金净额-80,825.9450,766.9250,766.92
  投资活动现金流入小计123,096,868.62560,430,012.07475,253,588.15344,918,169.33
  购建固定资产、无形资产和其他长期资产支付的现金7,917,432.8523,819,716.817,915,776.239,566,325.41
  投资支付的现金75,976,062682,225,852524,985,192375,654,794
  投资活动现金流出小计83,893,494.85706,045,568.8542,900,968.23385,221,119.41
  投资活动产生的现金流量净额39,203,373.77-145,615,556.73-67,647,380.08-40,302,950.08
三、筹资活动产生的现金流量:
  吸收投资收到的现金-12,626,905.0512,955,659.6-
  筹资活动现金流入平衡项目-00-
  筹资活动现金流入小计-12,626,905.0512,955,659.6-
  分配股利、利润或偿付利息支付的现金-39,700,158.639,696,972.9139,696,972.91
  支付其他与筹资活动有关的现金-1,122,214.95956,920.1791,169.8
  筹资活动现金流出平衡项目-000
  筹资活动现金流出小计-40,822,373.5540,653,893.0140,488,142.71
  筹资活动产生的现金流量净额平衡项目-000
  筹资活动产生的现金流量净额--28,195,468.5-27,698,233.41-40,488,142.71
四、汇率变动对现金及现金等价物的影响-360,776.12321,959.72476,542.53495,324.34
五、现金及现金等价物净增加额42,044,822.65-33,622,386.94-11,110,882.4-23,774,815.15
  加:期初现金及现金等价物余额19,595,214.3353,217,601.2753,217,601.2753,217,601.27
  期末现金及现金等价物余额61,640,036.9819,595,214.3342,106,718.8729,442,786.12
补充资料:
  净利润-113,128,438.52-47,299,142.7
  资产减值准备-2,877,417.21--23,067.44
  固定资产和投资性房地产折旧-18,549,801.21-9,387,949.9
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-18,549,801.21-9,387,949.9
  无形资产摊销-8,136,198.17-4,007,817.59
  长期待摊费用摊销-572,942.03-381,918.21
  处置固定资产、无形资产和其他长期资产的损失--6,437.07--
  固定资产报废损失-2,697,376.44-2,106,750.41
  公允价值变动损失--185,028.55-446,766.21
  财务费用--727,437.27--1,374,104.05
  投资损失--2,938,077.08--1,785,129.36
  递延所得税-97,826.88--411,822.16
  其中:递延所得税资产减少-108,179.18--69,354.19
    递延所得税负债增加--10,352.3--342,467.97
  存货的减少--5,287,744.67--3,696,398.97
  经营性应收项目的减少--3,934,790.29-7,005,958.55
  经营性应付项目的增加--3,407,332.82--7,484,739.1
  其他-9,485,037.21--
  现金的期末余额-19,595,214.33-29,442,786.12
  减:现金的期初余额-53,217,601.27-53,217,601.27
  现金及现金等价物的净增加额--33,622,386.94--23,774,815.15
公告日期2026-04-282026-04-282025-10-242025-08-22
审计意见(境内)标准无保留意见
TOP↑